UPLYFT For Lymphoma Survivors — Stella

stellabeta Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

UPLYFT For Lymphoma Survivors — Stella

Recruiting

Back to Lymphoma trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

United States

Dana-Farber Cancer Institute, Boston, Massachusetts

Key details

Sponsor

Dana-Farber Cancer Institute

Collaborators

American Society of Hematology

Enrollment target

~74 participants

Started

February 2022

Primary completion

May 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov